Targeted Therapy in Advanced and Metastatic Non-Small Cell Lung Cancer. An Update on Treatment of the Most Important Actionable Oncogenic Driver Alterations
David König(University Hospital of Basel), Sacha I. Rothschild(University Hospital of Basel)
Cited by 112
Related Papers
Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events
|Journal for ImmunoTherapy of Cancer|2018|131